News

Hospital Joins Growing List of Leading Heart Centers Worldwide With Two or More Sensei X Robotic Catheter Systems Hansen Medical, Inc., a global leader in flexible robotics and the developer of robotic technology for accurate 3D control of...

On Dec. 22, 2011, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center completed its first robotic cardiac ablation procedure with the Stereotaxis Epoch™ Platform for complex cardiac arrhythmias. The Epoch Platform is a...

Pharmacogenetic Patents Have the Potential to Extend Drug Candidate’s Potential Commercial Exclusivity Period If Regulatory Approval Obtained ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for...

Researchers Achieve 98% Acute Pulmonary Vein Isolation, with 77% of Patients in Sinus Rhythm at Approximately Nine Months Follow-up CardioFocus, Inc., developer of the HeartLight™ Endoscopic Ablation System (EAS) for the treatment of atrial...

St. Jude Medical, a global medical device company, announced the publication of results from the ASSERT cohort study in the New England Journal of Medicine (NEJM). The ASSERT study, or ASymptomatic AF and Stroke Evaluation in Pacemaker...

Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has announced the European launch of the TactiCath 75 force-sensing...

Biosense Webster Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the completion of enrollment in their latest groundbreaking clinical trial, the SMART-AF Investigational Device Exemption (IDE)...

nContact, Inc., the leading innovator in epicardial ablation devices, announced that its recently launched corporate website, www.ncontactinc.com, has won a 2011 Interactive Media Award for Best in Class Medical Site, presented by the...

CHICAGO – The anticoagulant dabigatran is associated with an increased risk of myocardial infarction (heart attack) or acute coronary syndrome in a broad spectrum of patients when tested against some other medicines, according to a study...

FDA Grants Expedited Review Status for Subcutaneous Implantable Defibrillator, an Important Alternative for Patients at Risk of Sudden Cardiac Arrest (SCA) Cameron Health, Inc.announced that it has submitted the Premarket Approval (PMA)...